Leukemia Research
Volume 33, Issue 11 , Pages 1481-1484, November 2009

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

  • Arturo Vega-Ruiz

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Jorge E. Cortes

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Matjaz Sever

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Taghi Manshouri

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Alfonso Quintás-Cardama

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Raja Luthra

      Affiliations

    • Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Hagop M. Kantarjian

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
  • ,
  • Srdan Verstovsek

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • Corresponding Author InformationCorresponding author at: UT MD Anderson Cancer Center, Department of Leukemia, Unit 428, 1515 Holcombe Boulevard, Houston, TX 77030, United States. Tel.: +1 713 745 3429; fax: +1 713 794 4297.

Received 25 November 2008; received in revised form 18 December 2008; accepted 23 December 2008. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(08)00567-5

doi:10.1016/j.leukres.2008.12.020

Leukemia Research
Volume 33, Issue 11 , Pages 1481-1484, November 2009